Emcure Pharmaceuticals consolidated net profit rises 28.81% in the March 2026 quarter

Sales rise 16.70% to Rs 2469.70 crore

Net profit of Emcure Pharmaceuticals rose 28.81% to Rs 243.40 crore in the quarter ended March 2026 as against Rs 188.96 crore during the previous quarter ended March 2025. Sales rose 16.70% to Rs 2469.70 crore in the quarter ended March 2026 as against Rs 2116.25 crore during the previous quarter ended March 2025.

For the full year,net profit rose 35.67% to Rs 924.36 crore in the year ended March 2026 as against Rs 681.33 crore during the previous year ended March 2025. Sales rose 16.56% to Rs 9203.54 crore in the year ended March 2026 as against Rs 7896.00 crore during the previous year ended March 2025.

Particulars	Quarter Ended			Year Ended
	Mar. 2026	Mar. 2025	% Var.	Mar. 2026	Mar. 2025	% Var.
Sales	2469.70	2116.25	17	9203.54	7896.00	17
OPM %	19.42	19.02	-	20.26	18.67	-
PBDT	437.14	367.83	19	1733.54	1365.86	27
PBT	330.88	270.99	22	1318.49	981.73	34
NP	243.40	188.96	29	924.36	681.33	36

Powered by Capital Market - Live News